Verse Medical develops software infrastructure to enable hospital-quality care in patients' homes, positioning itself as an AI-enabled Durable Medical Equipment (DME) provider. The company operates across 47 states in the United States, working within the healthcare, DME, and home healthcare sectors. It is backed by top healthcare and technology investors and is at the Series C stage of funding.
The company's main product, the Verse Platform, connects providers, payors, and patients by consolidating referrals, orders, and communications into a single system. It is designed to replace outdated processes such as faxes and phone tag, and the company reports that it saves clinics 10-15 hours per week.
Verse Medical's technical work spans artificial intelligence and healthcare software. The company states a commitment to making high-quality in-home care accessible and describes itself as growing rapidly with plans for continued expansion.
